Trial
NCT06773455
Tralokinumab for Dupilumab Failures
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Psoriasis Treatment Center of Central New Jersey
Collaborators
LEO Pharma
Condition
Atopic Dermatitis
Intervention
tralokinumab
Why stopped
Principal Investigator retired
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-22